834 filings
Page 5 of 42
4
Seely Lynn
23 Jun 23
Blueprint Medicines / Lynn Seely ownership change
7:06pm
4
John Tsai
23 Jun 23
Blueprint Medicines / John Tsai ownership change
7:05pm
4
Dable Habib J
23 Jun 23
Blueprint Medicines / Habib J Dable ownership change
7:04pm
4
Lonnel Coats
23 Jun 23
Blueprint Medicines / LONNEL COATS ownership change
7:04pm
4
BPMC
Blueprint Medicines Corp
23 Jun 23
Blueprint Medicines / Alexis Borisy ownership change
7:03pm
4
Lydon Nicholas
23 Jun 23
Blueprint Medicines / Nicholas Lydon ownership change
7:02pm
4
BPMC
Blueprint Medicines Corp
23 Jun 23
Blueprint Medicines / Daniella Beckman ownership change
7:00pm
4
BPMC
Blueprint Medicines Corp
7 Jun 23
Blueprint Medicines / Percy H. Carter ownership change
7:52pm
4
L. Becker Hewes
7 Jun 23
Blueprint Medicines / L. Becker Hewes ownership change
7:48pm
8-K
BPMC
Blueprint Medicines Corp
25 May 23
Entry into a Material Definitive Agreement
4:32pm
8-K
BPMC
Blueprint Medicines Corp
22 May 23
FDA Approves AYVAKIT® (avapritinib) as the First and Only Treatment for Indolent Systemic Mastocytosis
4:53pm
10-Q
2023 Q1
BPMC
Blueprint Medicines Corp
Quarterly report
4 May 23
4:23pm
8-K
BPMC
Blueprint Medicines Corp
4 May 23
Blueprint Medicines Reports First Quarter 2023 Results
7:18am
ARS
2022 FY
BPMC
Blueprint Medicines Corp
28 Apr 23
Annual report to shareholders
5:47pm
DEFA14A
BPMC
Blueprint Medicines Corp
28 Apr 23
Additional proxy soliciting materials
5:30pm
DEF 14A
BPMC
Blueprint Medicines Corp
Definitive proxy
28 Apr 23
5:30pm
8-K
BPMC
Blueprint Medicines Corp
28 Mar 23
Blueprint Medicines Announces Lift of Partial Clinical Hold on Phase 1/2 VELA Trial of BLU-222
5:04pm
4
Christopher K. Murray
8 Mar 23
Blueprint Medicines / Christopher K. Murray ownership change
9:38pm
4
Christina Rossi
8 Mar 23
Blueprint Medicines / Christina Rossi ownership change
9:36pm
4
Fouad Namouni
8 Mar 23
Blueprint Medicines / Fouad Namouni ownership change
9:34pm